jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Jan. 07, 2026

Jan. 07, 2026

jRCTs032250617

Efficacy of the Functional Improvement Effects of Different Stimulation Methods of Repetitive Transcranial Magnetic Stimulation for Upper Limb Paralysis After Stroke: Randomized Controlled Trial

Efficacy of rTMS for upper limb paralysis after stroke

Kikuchi Naohisa

Chiba Rehabilitation Center

1-45-2 Hondacho, Midori-ku, Chiba city

+81-43-291-1831

kikuchi@chiba-reha.jp

Murayama Takashi

Chiba Rehabilitation Center

1-45-2 Hondacho, Midori-ku, Chiba city

+81-43-291-1831

takashi.murayama@chiba-reha.jp

Recruiting

Jan. 07, 2026

88

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

Study1
(1) Age: 20-80
(2) Under the agreement with written consent form
(3) Diagnosed as stroke by a physician
(4) Inpatient at Chiba Rehabilitation Center
(5) 2 months after onset
(6) MEPs appears
(7) Fugl-Meyer Assessment for upper extremity item of 20 or more
(8) The weekly upper extremity motor score is limited to a change within the standard error for two consecutive weeks
Study2
(1) Age: 20-80
(2) Under the agreement with written consent form
(3) Diagnosed as stroke by a physician
(4) Inpatient at Chiba Rehabilitation Center
(5) 2 months after onset
(6) MEPs does not appear.
(7) Fugl-Meyer Assessment for upper extremity item are 19 points or less
(8) The weekly upper extremity motor score is limited to a change within the standard error for two consecutive weeks

(1) Fit into following cases
History of harmful sides effects due to magnetic or electrical stimulation. History of seizure or epilepsy. Disease or injury of head, brain, peripheral nerves including brain surgery prior to the onset of the current illness or injury. Medical device implantation such as cardiac pacemaker, neurosurgical clips, battery or pumps, non-titanium metal implants in the head or the stimulus target area of trunk. Chronic severe migraine, Suspicion of pregnancy
(2) Buried metal cannot be identified as titanium.
(3) Inappropriate patient decided by a physician
(4) Current participation in clinical trials for an approved drug or clinical device
(5) History of botulinum toxin therapy within 3 months
(6) Over 57 points the FMA for upper extremity item

20age old over
80age old under

Both

Stroke

repetitive Transcranial Magnetic Stimulation

Fugl-Meyer Assessment for upper extremity item

Subtest scores Fugl-Meyer Assessment for upper extremity item, ARAT (Action Research Arm Test), BBT(Box & Block Test), Motor evoked potential elicited by transcranial magnetic stimulation, ipsilateral silent period by transcranial magnetic stimulation *Study2 only, Magnetic resonance imaging, Safety Assessments

Yokohama City University Certified Instit
3-9, Fukuura, Kanazawa-ku, Yokohama-shi, Kanagawa, Japan, Kanagawa

+81-45-370-7627

ycu_crb@yokohama-cu.ac.jp
Approval

Sept. 04, 2025

Yes

Data registration and storage will be done using UHCT ACReSS (UHCT Alliance Clinical Research Supporting System).

none